1. Share Talk

Nigel Theobald

15May 2017

N4 Pharma PLC (AIM:N4P) Filing of Patents and Sildenafil Update

 

RNS Number : 0666F

N4 Pharma Plc (AIM: N4P), a specialist pharmaceutical company which reformulates existing drugs and vaccines to improve their performance, is pleased to announce the filing of its Patent Cooperation Treaty (“PCT”) patent application for its sildenafil reformulation and provide an update on the work done by the Company in the year to date as it moves towards clinical trials. In addition, the Company is pleased to announce the filing of two new patents expanding its potential reformulation product pipeline to five.